{"entity":{"type":"insider","cik":"0001362148","url":"/insider/0001362148","json_url":"/insider/0001362148.json","name":"Lynch Samuel Eugene","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":177,"n_filings":29,"first":"2006-05-15","last":"2012-03-30","span_basis":"filed_date"},"name_variants":[{"name":"Lynch Samuel Eugene","source":"filing","n_filings":29,"first_seen":"2006-05-15","last_seen":"2012-03-30"}],"transactions":[{"id":3070494,"accession":"0001209191-12-020640","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-12-020640","line_url":"/filing/0001209191-12-020640#line-3","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":2.4,"price_display":"2.40","price_state":"stated","total_value":48000.0,"total_display":"48,000.00","shares_owned_after":1239391.0,"shares_owned_after_display":"1,239,391","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-30","filed_date":"2012-03-30","scope":"insider"},{"id":3070487,"accession":"0001209191-12-020640","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-020640","line_url":"/filing/0001209191-12-020640#line-2","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19362.0,"shares_display":"19,362","price_per_share":2.4601,"price_display":"2.46","price_state":"stated","total_value":47632.4562,"total_display":"47,632.46","shares_owned_after":1219391.0,"shares_owned_after_display":"1,219,391","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-30","filed_date":"2012-03-30","scope":"insider"},{"id":3070480,"accession":"0001209191-12-020640","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-020640","line_url":"/filing/0001209191-12-020640#line-1","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30638.0,"shares_display":"30,638","price_per_share":2.3791,"price_display":"2.38","price_state":"stated","total_value":72890.8658,"total_display":"72,890.87","shares_owned_after":1200029.0,"shares_owned_after_display":"1,200,029","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-29","filed_date":"2012-03-30","scope":"insider"},{"id":3070420,"accession":"0001209191-12-020300","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-12-020300","line_url":"/filing/0001209191-12-020300#line-3","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.35,"price_display":"2.35","price_state":"stated","total_value":23500.0,"total_display":"23,500.00","shares_owned_after":1166691.0,"shares_owned_after_display":"1,166,691","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-23","filed_date":"2012-03-28","scope":"insider"},{"id":3070413,"accession":"0001209191-12-020300","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-020300","line_url":"/filing/0001209191-12-020300#line-2","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2700.0,"shares_display":"2,700","price_per_share":2.35,"price_display":"2.35","price_state":"stated","total_value":6345.0,"total_display":"6,345.00","shares_owned_after":1169391.0,"shares_owned_after_display":"1,169,391","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-23","filed_date":"2012-03-28","scope":"insider"},{"id":3070408,"accession":"0001209191-12-020300","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-020300","line_url":"/filing/0001209191-12-020300#line-1","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":450.0,"shares_display":"450","price_per_share":2.35,"price_display":"2.35","price_state":"stated","total_value":1057.5,"total_display":"1,057.50","shares_owned_after":5550.0,"shares_owned_after_display":"5,550","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-03-23","filed_date":"2012-03-28","scope":"insider"},{"id":9143719,"accession":"0001209191-11-037155","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-037155","line_url":"/filing/0001209191-11-037155#line-1","is_derivative":false,"issuer_cik":"0000764402","issuer_name":"GREEN BANKSHARES, INC.","issuer_ticker":"GRNB","issuer_name_source":null,"issuer_url":"/issuer/0000764402","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director","officer_title":null,"security_title":"GRNB Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1518.0,"shares_display":"1,518","price_per_share":2.62,"price_display":"2.62","price_state":"stated","total_value":3977.16,"total_display":"3,977.16","shares_owned_after":5368.0,"shares_owned_after_display":"5,368","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-06-30","filed_date":"2011-07-01","scope":"insider"},{"id":9085129,"accession":"0001209191-11-029613","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-029613","line_url":"/filing/0001209191-11-029613#line-2","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":7.9,"price_display":"7.90","price_state":"stated","total_value":79000.0,"total_display":"79,000.00","shares_owned_after":895912.0,"shares_owned_after_display":"895,912","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-18","filed_date":"2011-05-19","scope":"insider"},{"id":9085128,"accession":"0001209191-11-029613","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-029613","line_url":"/filing/0001209191-11-029613#line-1","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":7.75,"price_display":"7.75","price_state":"stated","total_value":23250.0,"total_display":"23,250.00","shares_owned_after":898912.0,"shares_owned_after_display":"898,912","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-18","filed_date":"2011-05-19","scope":"insider"},{"id":9267708,"accession":"0001209191-11-022973","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-022973","line_url":"/filing/0001209191-11-022973#line-1","is_derivative":false,"issuer_cik":"0001362148","issuer_name":"GREEN BANKSHARES, INC.","issuer_ticker":"GRNB","issuer_name_source":null,"issuer_url":"/issuer/0001362148","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director","officer_title":null,"security_title":"GRNB - Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":192.0,"shares_display":"192","price_per_share":2.79,"price_display":"2.79","price_state":"stated","total_value":535.68,"total_display":"535.68","shares_owned_after":3850.0,"shares_owned_after_display":"3,850","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-12","filed_date":"2011-04-15","scope":"insider"},{"id":9026810,"accession":"0001209191-11-022824","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-022824","line_url":"/filing/0001209191-11-022824#line-1","is_derivative":false,"issuer_cik":"0000764402","issuer_name":"GREEN BANKSHARES, INC.","issuer_ticker":"GRNB","issuer_name_source":null,"issuer_url":"/issuer/0000764402","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director","officer_title":null,"security_title":"GRNB - Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":192.0,"shares_display":"192","price_per_share":2.79,"price_display":"2.79","price_state":"stated","total_value":535.68,"total_display":"535.68","shares_owned_after":1829.0,"shares_owned_after_display":"1,829","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-12","filed_date":"2011-04-13","scope":"insider"},{"id":5816827,"accession":"0001209191-09-059055","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-059055","line_url":"/filing/0001209191-09-059055#line-2","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":11.29,"price_display":"11.29","price_state":"stated","total_value":33870.0,"total_display":"33,870.00","shares_owned_after":838690.0,"shares_owned_after_display":"838,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-29","filed_date":"2009-12-30","scope":"insider"},{"id":5816824,"accession":"0001209191-09-059055","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-059055","line_url":"/filing/0001209191-09-059055#line-1","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":11.56,"price_display":"11.56","price_state":"stated","total_value":34680.0,"total_display":"34,680.00","shares_owned_after":841690.0,"shares_owned_after_display":"841,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-28","filed_date":"2009-12-30","scope":"insider"},{"id":5788331,"accession":"0001209191-09-057243","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-057243","line_url":"/filing/0001209191-09-057243#line-2","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":12.03,"price_display":"12.03","price_state":"stated","total_value":36090.0,"total_display":"36,090.00","shares_owned_after":844690.0,"shares_owned_after_display":"844,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-15","filed_date":"2009-12-16","scope":"insider"},{"id":5788329,"accession":"0001209191-09-057243","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-057243","line_url":"/filing/0001209191-09-057243#line-1","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":12.32,"price_display":"12.32","price_state":"stated","total_value":36960.0,"total_display":"36,960.00","shares_owned_after":847690.0,"shares_owned_after_display":"847,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-14","filed_date":"2009-12-16","scope":"insider"},{"id":5770140,"accession":"0001209191-09-055525","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-055525","line_url":"/filing/0001209191-09-055525#line-2","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":11.24,"price_display":"11.24","price_state":"stated","total_value":33720.0,"total_display":"33,720.00","shares_owned_after":850690.0,"shares_owned_after_display":"850,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-03","filed_date":"2009-12-04","scope":"insider"},{"id":5770137,"accession":"0001209191-09-055525","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-055525","line_url":"/filing/0001209191-09-055525#line-1","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":10.94,"price_display":"10.94","price_state":"stated","total_value":32820.0,"total_display":"32,820.00","shares_owned_after":853690.0,"shares_owned_after_display":"853,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-02","filed_date":"2009-12-04","scope":"insider"},{"id":5806478,"accession":"0001209191-09-053380","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-053380","line_url":"/filing/0001209191-09-053380#line-2","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":11.64,"price_display":"11.64","price_state":"stated","total_value":34920.0,"total_display":"34,920.00","shares_owned_after":856690.0,"shares_owned_after_display":"856,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-17","filed_date":"2009-11-18","scope":"insider"},{"id":5806476,"accession":"0001209191-09-053380","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-053380","line_url":"/filing/0001209191-09-053380#line-1","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":11.8,"price_display":"11.80","price_state":"stated","total_value":35400.0,"total_display":"35,400.00","shares_owned_after":859690.0,"shares_owned_after_display":"859,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-16","filed_date":"2009-11-18","scope":"insider"},{"id":6044092,"accession":"0001209191-09-051401","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-051401","line_url":"/filing/0001209191-09-051401#line-2","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":11.7,"price_display":"11.70","price_state":"stated","total_value":35100.0,"total_display":"35,100.00","shares_owned_after":862690.0,"shares_owned_after_display":"862,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-05","filed_date":"2009-11-06","scope":"insider"},{"id":6044088,"accession":"0001209191-09-051401","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-051401","line_url":"/filing/0001209191-09-051401#line-1","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":11.63,"price_display":"11.63","price_state":"stated","total_value":34890.0,"total_display":"34,890.00","shares_owned_after":865690.0,"shares_owned_after_display":"865,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-04","filed_date":"2009-11-06","scope":"insider"},{"id":5806317,"accession":"0001209191-09-049644","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-09-049644","line_url":"/filing/0001209191-09-049644#line-4","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":13.85,"price_display":"13.85","price_state":"stated","total_value":41550.0,"total_display":"41,550.00","shares_owned_after":870190.0,"shares_owned_after_display":"870,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-21","filed_date":"2009-10-23","scope":"insider"},{"id":5806315,"accession":"0001209191-09-049644","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-09-049644","line_url":"/filing/0001209191-09-049644#line-3","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":13.85,"price_display":"13.85","price_state":"stated","total_value":20775.0,"total_display":"20,775.00","shares_owned_after":868690.0,"shares_owned_after_display":"868,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-21","filed_date":"2009-10-23","scope":"insider"},{"id":5806312,"accession":"0001209191-09-049644","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-049644","line_url":"/filing/0001209191-09-049644#line-2","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":14.22,"price_display":"14.22","price_state":"stated","total_value":42660.0,"total_display":"42,660.00","shares_owned_after":874690.0,"shares_owned_after_display":"874,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-20","filed_date":"2009-10-23","scope":"insider"},{"id":5806310,"accession":"0001209191-09-049644","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-049644","line_url":"/filing/0001209191-09-049644#line-1","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":14.21,"price_display":"14.21","price_state":"stated","total_value":21315.0,"total_display":"21,315.00","shares_owned_after":873190.0,"shares_owned_after_display":"873,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-20","filed_date":"2009-10-23","scope":"insider"},{"id":5703209,"accession":"0001209191-09-047982","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-09-047982","line_url":"/filing/0001209191-09-047982#line-3","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":12.5746,"price_display":"12.57","price_state":"stated","total_value":37723.8,"total_display":"37,723.80","shares_owned_after":877690.0,"shares_owned_after_display":"877,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-06","filed_date":"2009-10-07","scope":"insider"},{"id":5703208,"accession":"0001209191-09-047982","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-047982","line_url":"/filing/0001209191-09-047982#line-2","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":12.5617,"price_display":"12.56","price_state":"stated","total_value":18842.55,"total_display":"18,842.55","shares_owned_after":880690.0,"shares_owned_after_display":"880,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-06","filed_date":"2009-10-07","scope":"insider"},{"id":5703207,"accession":"0001209191-09-047982","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-047982","line_url":"/filing/0001209191-09-047982#line-1","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":11.5046,"price_display":"11.50","price_state":"stated","total_value":34513.8,"total_display":"34,513.80","shares_owned_after":882190.0,"shares_owned_after_display":"882,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-05","filed_date":"2009-10-07","scope":"insider"},{"id":5769464,"accession":"0001209191-09-045795","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-09-045795","line_url":"/filing/0001209191-09-045795#line-4","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":12.986,"price_display":"12.99","price_state":"stated","total_value":38958.0,"total_display":"38,958.00","shares_owned_after":886690.0,"shares_owned_after_display":"886,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-24","filed_date":"2009-09-25","scope":"insider"},{"id":5769463,"accession":"0001209191-09-045795","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-09-045795","line_url":"/filing/0001209191-09-045795#line-3","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":12.9835,"price_display":"12.98","price_state":"stated","total_value":19475.25,"total_display":"19,475.25","shares_owned_after":885190.0,"shares_owned_after_display":"885,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-24","filed_date":"2009-09-25","scope":"insider"},{"id":5769462,"accession":"0001209191-09-045795","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-045795","line_url":"/filing/0001209191-09-045795#line-2","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":13.0479,"price_display":"13.05","price_state":"stated","total_value":39143.7,"total_display":"39,143.70","shares_owned_after":891190.0,"shares_owned_after_display":"891,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-23","filed_date":"2009-09-25","scope":"insider"},{"id":5769461,"accession":"0001209191-09-045795","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-045795","line_url":"/filing/0001209191-09-045795#line-1","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":13.115,"price_display":"13.12","price_state":"stated","total_value":19672.5,"total_display":"19,672.50","shares_owned_after":889690.0,"shares_owned_after_display":"889,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-23","filed_date":"2009-09-25","scope":"insider"},{"id":5655028,"accession":"0001209191-09-043954","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-043954","line_url":"/filing/0001209191-09-043954#line-2","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":11.9944,"price_display":"11.99","price_state":"stated","total_value":35983.2,"total_display":"35,983.20","shares_owned_after":894190.0,"shares_owned_after_display":"894,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-10","filed_date":"2009-09-11","scope":"insider"},{"id":5655027,"accession":"0001209191-09-043954","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-043954","line_url":"/filing/0001209191-09-043954#line-1","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":12.0058,"price_display":"12.01","price_state":"stated","total_value":36017.4,"total_display":"36,017.40","shares_owned_after":897190.0,"shares_owned_after_display":"897,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-09","filed_date":"2009-09-11","scope":"insider"},{"id":5637573,"accession":"0001209191-09-042290","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-042290","line_url":"/filing/0001209191-09-042290#line-2","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":11.4676,"price_display":"11.47","price_state":"stated","total_value":34402.8,"total_display":"34,402.80","shares_owned_after":900190.0,"shares_owned_after_display":"900,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-26","filed_date":"2009-08-27","scope":"insider"},{"id":5637572,"accession":"0001209191-09-042290","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-042290","line_url":"/filing/0001209191-09-042290#line-1","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":11.7167,"price_display":"11.72","price_state":"stated","total_value":35150.1,"total_display":"35,150.10","shares_owned_after":903190.0,"shares_owned_after_display":"903,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-25","filed_date":"2009-08-27","scope":"insider"},{"id":5619264,"accession":"0001209191-09-040706","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-040706","line_url":"/filing/0001209191-09-040706#line-2","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":10.792,"price_display":"10.79","price_state":"stated","total_value":32376.0,"total_display":"32,376.00","shares_owned_after":906190.0,"shares_owned_after_display":"906,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-13","filed_date":"2009-08-14","scope":"insider"},{"id":5619263,"accession":"0001209191-09-040706","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-040706","line_url":"/filing/0001209191-09-040706#line-1","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":10.8465,"price_display":"10.85","price_state":"stated","total_value":32539.5,"total_display":"32,539.50","shares_owned_after":909190.0,"shares_owned_after_display":"909,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-12","filed_date":"2009-08-14","scope":"insider"},{"id":5665481,"accession":"0001209191-09-038362","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001209191-09-038362","line_url":"/filing/0001209191-09-038362#line-25","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":209.0,"shares_display":"209","price_per_share":10.12,"price_display":"10.12","price_state":"stated","total_value":2115.08,"total_display":"2,115.08","shares_owned_after":913190.0,"shares_owned_after_display":"913,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-07-30","filed_date":"2009-07-31","scope":"insider"},{"id":5665480,"accession":"0001209191-09-038362","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001209191-09-038362","line_url":"/filing/0001209191-09-038362#line-24","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":203.0,"shares_display":"203","price_per_share":10.05,"price_display":"10.05","price_state":"stated","total_value":2040.15,"total_display":"2,040.15","shares_owned_after":914009.0,"shares_owned_after_display":"914,009","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-07-30","filed_date":"2009-07-31","scope":"insider"},{"id":5665479,"accession":"0001209191-09-038362","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001209191-09-038362","line_url":"/filing/0001209191-09-038362#line-23","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":203.0,"shares_display":"203","price_per_share":10.03,"price_display":"10.03","price_state":"stated","total_value":2036.09,"total_display":"2,036.09","shares_owned_after":914212.0,"shares_owned_after_display":"914,212","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-07-30","filed_date":"2009-07-31","scope":"insider"},{"id":5665478,"accession":"0001209191-09-038362","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001209191-09-038362","line_url":"/filing/0001209191-09-038362#line-22","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":10.21,"price_display":"10.21","price_state":"stated","total_value":2042.0,"total_display":"2,042.00","shares_owned_after":912390.0,"shares_owned_after_display":"912,390","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-07-30","filed_date":"2009-07-31","scope":"insider"},{"id":5665477,"accession":"0001209191-09-038362","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001209191-09-038362","line_url":"/filing/0001209191-09-038362#line-21","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":10.18,"price_display":"10.18","price_state":"stated","total_value":2036.0,"total_display":"2,036.00","shares_owned_after":912690.0,"shares_owned_after_display":"912,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-07-30","filed_date":"2009-07-31","scope":"insider"},{"id":5665476,"accession":"0001209191-09-038362","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001209191-09-038362","line_url":"/filing/0001209191-09-038362#line-20","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":10.1,"price_display":"10.10","price_state":"stated","total_value":2020.0,"total_display":"2,020.00","shares_owned_after":913590.0,"shares_owned_after_display":"913,590","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-07-30","filed_date":"2009-07-31","scope":"insider"},{"id":5665475,"accession":"0001209191-09-038362","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001209191-09-038362","line_url":"/filing/0001209191-09-038362#line-19","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":9.95,"price_display":"9.95","price_state":"stated","total_value":1990.0,"total_display":"1,990.00","shares_owned_after":914933.0,"shares_owned_after_display":"914,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-07-30","filed_date":"2009-07-31","scope":"insider"},{"id":5665474,"accession":"0001209191-09-038362","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001209191-09-038362","line_url":"/filing/0001209191-09-038362#line-18","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":191.0,"shares_display":"191","price_per_share":10.11,"price_display":"10.11","price_state":"stated","total_value":1931.01,"total_display":"1,931.01","shares_owned_after":913399.0,"shares_owned_after_display":"913,399","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-07-30","filed_date":"2009-07-31","scope":"insider"},{"id":5665473,"accession":"0001209191-09-038362","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001209191-09-038362","line_url":"/filing/0001209191-09-038362#line-17","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150.0,"shares_display":"150","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":1500.0,"total_display":"1,500.00","shares_owned_after":914540.0,"shares_owned_after_display":"914,540","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-07-30","filed_date":"2009-07-31","scope":"insider"},{"id":5665472,"accession":"0001209191-09-038362","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001209191-09-038362","line_url":"/filing/0001209191-09-038362#line-16","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":143.0,"shares_display":"143","price_per_share":9.99,"price_display":"9.99","price_state":"stated","total_value":1428.57,"total_display":"1,428.57","shares_owned_after":914690.0,"shares_owned_after_display":"914,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-07-30","filed_date":"2009-07-31","scope":"insider"},{"id":5665471,"accession":"0001209191-09-038362","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001209191-09-038362","line_url":"/filing/0001209191-09-038362#line-15","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":112.0,"shares_display":"112","price_per_share":10.14,"price_display":"10.14","price_state":"stated","total_value":1135.68,"total_display":"1,135.68","shares_owned_after":913078.0,"shares_owned_after_display":"913,078","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-07-30","filed_date":"2009-07-31","scope":"insider"},{"id":5665470,"accession":"0001209191-09-038362","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001209191-09-038362","line_url":"/filing/0001209191-09-038362#line-14","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001362148","owner_name":"Lynch Samuel Eugene","owner_url":"/insider/0001362148","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":110.0,"shares_display":"110","price_per_share":10.06,"price_display":"10.06","price_state":"stated","total_value":1106.6,"total_display":"1,106.60","shares_owned_after":913899.0,"shares_owned_after_display":"913,899","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-07-30","filed_date":"2009-07-31","scope":"insider"}],"next_cursor":"2009-07-30|5665470","ledger_fault":false,"count":{"value":177,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":19,"open_market":true},{"code":"S","label":"Open-market sale","n":158,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":177},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001138400","name":"BIOMIMETIC THERAPEUTICS, INC.","url":"/issuer/0001138400","role":"Director, Officer (President and CEO)","n_filings":26,"first_seen":"2006-05-15","last_seen":"2012-03-30"},{"type":"issuer","type_label":"ISSUER","cik":"0000764402","name":"GREEN BANKSHARES, INC.","url":"/issuer/0000764402","role":"Director","n_filings":3,"first_seen":"2011-04-13","last_seen":"2011-07-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001362148","retrieved_at":"2026-08-21T06:37:04+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}